Key Metrics
CiteScore 

10.3
Eigenfactor 

0.005 - 0.01
Impact Factor 

< 5
SJR 

Q1Pharmacology

SNIP 

2.16
Recommended pre-submission checks
Powered by 

Topics Covered on Clinical Pharmacokinetics
Clinical Pharmacokinetics Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1976 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Pharmacokinetics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical Pharmacokinetics
How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis.
- 5 Aug 2026
- Clinical pharmacokinetics
Exposure-Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular Lymphoma.
- 1 Aug 2026
- Clinical pharmacokinetics
Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate.
- 30 Jul 2026
- Clinical pharmacokinetics
Correction: Population Pharmacokinetic Analysis of Enalapril and Enalaprilat in Newly Treated Children with Heart Failure: Implications for Safe Dosing of Enalapril (LENA Studies).
- 29 Jul 2026
- Clinical pharmacokinetics
Physiologically Based Pharmacokinetic Modeling of Vedolizumab in Healthy Adults and Patients with Inflammatory Bowel Disease.
- 27 Jul 2026
- Clinical pharmacokinetics
The Effect of Food and the Proton Pump Inhibitor Rabeprazole on Binimetinib Pharmacokinetics in Healthy Participants.
- 27 Jul 2026
- Clinical pharmacokinetics
How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis.
- 5 Aug 2026
- Clinical pharmacokinetics
Exposure-Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular Lymphoma.
- 1 Aug 2026
- Clinical pharmacokinetics
Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate.
- 30 Jul 2026
- Clinical pharmacokinetics
Correction: Population Pharmacokinetic Analysis of Enalapril and Enalaprilat in Newly Treated Children with Heart Failure: Implications for Safe Dosing of Enalapril (LENA Studies).
- 29 Jul 2026
- Clinical pharmacokinetics
Physiologically Based Pharmacokinetic Modeling of Vedolizumab in Healthy Adults and Patients with Inflammatory Bowel Disease.
- 27 Jul 2026
- Clinical pharmacokinetics
The Effect of Food and the Proton Pump Inhibitor Rabeprazole on Binimetinib Pharmacokinetics in Healthy Participants.
- 27 Jul 2026
- Clinical pharmacokinetics